Abstract
The ninth American Society for Microbiology Conference on Biofilms was convened in-person on 13–17 November 2022 in Charlotte, NC. As the first of these conferences since prior to the start of the COVID-19 pandemic, the energy among the participants of the conference was clear, and the meeting was a tremendous success. The mixture of >330 oral and poster presentations resoundingly embodied the vitality of biofilm research across a wide range of topics and multiple scientific disciplines. Special activities, including a pre-conference symposium for early career researchers, further enhanced the attendee experience. As a general theme, the conference was deliberately structured to provide high levels of participation and engagement among early career scientists.
Original language | English |
---|---|
Journal | Journal of Bacteriology |
Volume | 205 |
Issue number | 10 |
DOIs | |
State | Published - 26 Oct 2023 |
Bibliographical note
Publisher Copyright:Copyright © 2023 American Society for Microbiology. All Rights Reserved.
Funding
Karen Visick (Chair) and Clay Fuqua (Co-Chair) greatly appreciate the contributions of all the individual scientists, who served in different capacities to make the ninth ASM Conference on Biofilms a success; the Organizing Committee, the Early Career Committee, the Image Analysis Workshop coordinators, and the DEI event conveners (see tables and text above). We are also thankful for the hard work and dedication of the ASM staff, present and former, who contributed to this conference during its development and implementation, Latonya Trower, Alexus Simpson, Kerry Kurowski, Delicia Hurdle, and Jennifer Tomb as well as several on-site ASM staff members. We also thank the participants who agreed to participate in the Lunch Table Career sessions organized by the ECS committee. We gratefully acknowledge the financial support of (i) an R13 grant from National Institutes of Allergy and Infectious Disease (Grant No. R13-AI164790), (ii) the Burroughs Wellcome Fund, (iii) the Gordon and Betty Moore Foundation, (iv) the National Biofilms Innovation Center (U.K.), (v) the Mark Shirtliff Biofilm Foundation, (vi) FEMS Microbiology Reviews, and (vii) the Dartmouth Cystic Fibrosis Research Center. Generous support from the private sector included contributions from Microgen DX, Symcel, Biofilm Control, Sharklet Technologies, and 3M. We gratefully acknowledge the support of (i) an R13 grant from National Institutes of Allergy and Infectious Disease (Grant No. R13-AI164790), (ii) the Burroughs Wellcome Fund, (iii) the Gordon and Betty Moore Foundation, (iv) the National Innovation Center (U.K.), (v) the Mark Foundation, (vi) FEMS Microbiology Reviews, and (vii) the Dartmouth Cystic Fibrosis Research Center. Generous support from the private sector included contributions from Microgen DX, Symcel, Control, Sharklet Technologies, and 3M.
Funders | Funder number |
---|---|
Clay Fuqua | |
Dartmouth Cystic Fibrosis Research Center | 3M |
Mark Foundation | |
Mark Shirtliff Biofilm Foundation | |
National Biofilms Innovation Center | |
National Innovation Center | |
National Institute of Allergy and Infectious Diseases | R13-AI164790 |
Burroughs Wellcome Fund | |
Gordon and Betty Moore Foundation |
Keywords
- biofilms
- conference review